000 01486 a2200397 4500
005 20250512200429.0
264 0 _c19841219
008 198412s 0 0 eng d
022 _a0033-3182
024 7 _a10.1016/S0033-3182(84)72962-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSwift, R M
245 0 0 _aEssential hypertension: psychiatric aspects and use of psychotropics.
_h[electronic resource]
260 _bPsychosomatics
_cOct 1984
300 _a737-42, 745 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenergic beta-Antagonists
_xadverse effects
650 0 4 _aAnalgesics
_xpharmacology
650 0 4 _aAnti-Anxiety Agents
_xpharmacology
650 0 4 _aAntidepressive Agents
_xpharmacology
650 0 4 _aAntihypertensive Agents
_xadverse effects
650 0 4 _aAntipsychotic Agents
_xpharmacology
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDepressive Disorder
_xchemically induced
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aHypnotics and Sedatives
_xpharmacology
650 0 4 _aLithium
_xpharmacology
650 0 4 _aLithium Carbonate
650 0 4 _aPsychotropic Drugs
_xpharmacology
650 0 4 _aReserpine
_xadverse effects
650 0 4 _aVasodilator Agents
_xadverse effects
700 1 _aBlack, H R
773 0 _tPsychosomatics
_gvol. 25
_gno. 10
_gp. 737-42, 745
856 4 0 _uhttps://doi.org/10.1016/S0033-3182(84)72962-8
_zAvailable from publisher's website
999 _c6149676
_d6149676